Hannah Valantine, Director: BridgeBio Pharma BBIO Sell · Filed 23/12/19

Trade details

Type: Insider sale
Amount: $105,289.8
Shares · price: 2,915 sh · $36.12 a share
Held after: 1,764 sh
Stock: BridgeBio Pharma BBIO
Person: Hannah ValantineDirector
Trade date: 23/12/15
Filed: 23/12/19
Days to filing: 4 days

Sold 62.3% of holdings

Share of holding sold: 62.3%

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 23/11/15~24/01/14

Hannah Valantine's recent trades

Hannah ValantineDirector
Planned sale10b5-1 planCareDx
Planned sale10b5-1 plan
CareDx
CDNA
$856.2K
28,779 sh
$856.2K
Filed 07/16
Traded 07/16
Hannah ValantineDirector
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/24
Traded 06/22
Hannah ValantineDirector
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/24
Traded 06/23
Hannah ValantineDirector
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/23
Traded 06/23
Hannah ValantineDirector
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/22
Traded 06/22